Oct 23 |
Beam Therapeutics (BEAM): A Small-Cap Leader in Precision Genetic Medicine
|
Oct 17 |
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc
|
Sep 29 |
Beam Therapeutics: Still Holding Fast To Generous Valuation, Still Not A Buy
|
Sep 5 |
Why Is Beam Therapeutics (BEAM) Down 1.6% Since Last Earnings Report?
|
Aug 14 |
Beam Therapeutics Inc. (BEAM): Pioneering Genetic Medicine with CRISPR Technology
|
Aug 9 |
3 Gene Editing Stocks with Potential to Transform Medicine
|
Aug 8 |
Beam Therapeutics Second Quarter 2024 Earnings: Revenues Disappoint
|
Aug 7 |
Beam Therapeutics (BEAM) Q2 Earnings Beat, Revenues Miss
|
Aug 6 |
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates
|
Aug 6 |
Beam Therapeutics GAAP EPS of -$1.11 beats by $0.01, revenue of $11.77M misses by $1.28M
|